AB

Aadil Beigh

Director Director DIN 10101786
DIN 10101786 First appointment Apr 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2023
Shareholding value Locked Premium profile

About Aadil Beigh

Data last updated:

Aadil Beigh has 3 years in corporate governance. Formerly with 1 company, such as Uronephro Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 10101786
Primary Designation Director
First Appointment 05 Apr 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Uronephro Healthcare Private Limited U86100JK2023PTC014411
Director05 Apr 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Uronephro Healthcare Private Limited
Premium access

Shareholding and investment profile for Aadil Beigh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aadil Beigh

Aadil Beigh has 3 years in corporate governance. Formerly with 1 company, such as Uronephro Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Aadil Beigh is associated with 0 companies as a director.

Aadil Beigh has expertise in Healthcare.

Aadil Beigh has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available